Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
6,009 total articles
Adobe is trading near its 52-week low after a sectorwide SaaS sell-off, but fundamentals remain strong: free cash flow of $9.85B, EPS of $17.37, and a market cap near $110B imply the business can weather near-term disruption fears. This is a mid-term trade idea to buy a rebound while keeping a tight stop below key technical support.
<p>LSEG has been punished recently on headlines that large language models will commoditize financial data. That thesis misunderstands how exchanges monetize high-fidelity market content and risk services. This trade idea buys the dip: a disciplined long with clear stop and a long-term horizon to ride a valuation re-rate as investors refocus on rec…
Nebius Group (NBIS) just re-rated after beating 2025 revenue guidance and guiding for aggressive capacity expansion. The market is pricing explosive top-line growth into the stock while the company remains unprofitable and capex-hungry. For traders willing to accept execution and margin risk, there is a mid-term opportunity to buy the AI infrastruc…
Hercules Capital (HTGC) looks oversold after a sharp pullback to $15.72. The stock now yields ~10%, trades at ~1.3x book, and posts an EPS of $1.83 with a P/E around 8.5. Between strong credit covenants, recent growth in net investment income, and an upcoming dividend payment, the market’s fear of downside feels overstated. This is a mid-term trade…
MPLX offers a compelling mix of a high distribution, visible growth projects and conservative coverage that make it my preferred midstream pick versus higher-yielding peers like Western Midstream. I lay out an actionable long trade with entry at $56.83, a protective stop at $51.00 and a first target of $62.00 over a 180-trading-day horizon.
Celestica is trading like a growth hardware play but the market is pricing in near-term risk and wants clarity on 2027 demand and margins. The trade: add on weakness, hold into 2027 proof points tied to SD6300 and AI/data-center wins. Entry $275.00, stop $245.00, target $350.00; horizon: long term (180 trading days).
ASML's unique position in EUV lithography is seeing real order acceleration: a ~€39B backlog and net bookings up 48% in 2025. With a €12B buyback, a market cap of $545B and improving demand signals across AI infrastructure, the risk/reward into 2026-2028 looks favorable for a disciplined long. Entry, stop and target are provided with a 180-trading-…
Noah (NOAH) looks undervalued at roughly $815M market cap, P/E ~9.2 and P/B ~0.57 while navigating a structural compliance reset and global expansion. Technical momentum is constructive and the stock yields ~4.8%. This trade idea lays out a long entry, targets and stop, plus catalysts and risks tied to execution and regulatory clarity.
Globalstar's commercial execution is starting to show up in the numbers: highest annual revenue and a best-ever free-cash-flow year, a major capital infusion from Apple, and growing commercial partnerships. The balance sheet and FCF profile support a tactical long while competition from Starlink and elevated valuation argue for a disciplined stop. …
Duolingo is trading near its 52-week low after a year of headline-driven selling. The business generates strong free cash flow, has no net debt, and posts high returns on capital. With technicals oversold and valuation back to rational multiples, this is a tactical long with defined risk. Entry $112.90, stop $102.00, primary target $150.00 (mid-ter…
Cintas (CTAS) remains a high-quality, cash-generative business with double-digit ROE and consistent growth. Recent execution and a proposed UniFirst acquisition have been bullish catalysts, but the stock at ~$193 trades at ~41x earnings and >7x sales, leaving little margin for error. This trade idea recommends a short on strength with a mid-term ho…
Accelerant Holdings (ARX) has fallen from a $31 52-week high to near $10.67, trading like a distressed post-IPO name despite accelerating revenue and a profitable quarter as a public company. Fundamentals support a tactical long: strong revenue growth, improving unit economics, modest leverage and an enterprise value below $1B. This trade idea lays…
AppLovin's Axon AI stack and ad-monetization platform sit at the junction of mobile gaming growth and AI-driven ad effectiveness. The stock has already retraced from last year's highs, offering a mid-term swing opportunity: enter on a measured pullback, manage risk tightly, and aim for a re-rating driven by stronger monetization and improving margi…
Viking Therapeutics (VKTX) is a clinical-stage biotech focused on metabolic and endocrine disorders. Its dual GIP/GLP-1 candidate VK2735 is in phase 3 (injectable) and phase 2 (oral), positioning Viking as an under-the-radar competitor in the high-growth obesity therapeutics market. With a market cap of roughly $3.6B, a deep short-interest base, an…
Marvell is uniquely positioned at the intersection of custom AI processors and high-bandwidth optical connectivity. With a $66.6B market cap, improving margins, and recurring design-win momentum into hyperscale data centers, the stock looks actionable on a controlled pullback. This trade lays out a specific entry, stop and target with a 180-trading…
UiPath is moving from a pure-play RPA vendor into the orchestration layer for agentic AI. With accelerating enterprise adoption, improving profitability, and a valuation that still looks reasonable given ARR scale, this trade idea buys the setup around $11.30 with a mid-term horizon to capture re-rating as Maestro adoption and cross-sell accelerate…
Telkom Indonesia (TLKM) remains Indonesia's dominant telco and a critical digital infrastructure owner. The business combines predictable cash flows from mobile and fixed-line services with accelerating fiber and digital-services monetization. We view the current risk/reward as favorable: enter at $0.22, stop at $0.18, target $0.30 over a roughly 1…
Astera Labs is a pick-and-shovel play on hyperscaler AI deployments. The company’s expanded Scorpio X-Series roadmap and the secular lift in CAPEX for AI infrastructure support durable revenue growth. Valuation is rich, but the pullback from the 52-week high creates a risk/reward setup I’m willing to buy with a defined entry, stop and target over a…
GFL Environmental's sale of a majority stake in its Environmental Services arm and subsequent capital allocation plan (debt repayment plus buybacks) materially improves the balance sheet. At $43.32, shares trade at a modest P/E (~6.2) versus an enterprise value of $20.3B and an EV/EBITDA of ~27. The combination of durable waste cash flows, lower in…
Walmart is a low-risk core holding with clear optionality: steady cash flow, a $1.1T market cap and a high-return retail engine that can expand margins through omnichannel efficiency and Sam's Club membership growth. Valuation is full today, but the risk/reward becomes attractive on measured entry. This trade targets margin re-rating catalysts over…
Qfin trades at roughly 0.60x book and a sub-3x P/E while yielding more than 9%. That combination argues for a tactical long with a mid-term horizon: entry at $15.71, stop at $13.50 and a target of $22.00 over the next ~45 trading days. The trade rests on stable cash generation, an attractive dividend, and a technical setup that suggests a base is f…
Nebius rallied after beating 2025 ARR guidance and laying out an aggressive 2026 capacity and revenue plan. The market is pricing a big growth story - this trade targets further upside into validated capacity expansion while using a tight stop to limit downside if execution falters.
Lyft's post-earnings sell-off has left the stock technically oversold and fundamentally cheap: free cash flow of $1.116B and EV around $5.07B imply a low multiple that could snap back quickly. This is not a long-term endorsement of rideshare competition dynamics - it's a tactical, short-term trade to capture a mean-reversion bounce to near-term mov…
ARS Pharmaceuticals (SPRY) is printing accelerating neffy sales and expanding regulatory filings through licensing partners in multiple large markets. With revenue jumping to $32.5M in Q3 2025 and prescription volumes accelerating, the setup favors a tactical long over the next 45 trading days if price holds support and sentiment stabilizes. The tr…
Apollo’s credit franchise remains healthy: record origination >$300B, AUM near $938B and meaningful inflows. Market fear around credit losses and AI-driven sector rotation has driven price weakness that looks excessive versus fundamentals. Upgrade to long - tactical swing trade with clear entry, stop and target.
